Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


INTERVIEW: Green Cross Thinks Global With Plasma Products, Vaccines

This article was originally published in PharmAsia News

Executive Summary

Green Cross Holdings’ president sat down recently with PharmAsia News and talked about the South Korean pharma group's business plans for the year ahead and the need for the government to step up its efforts to help the industry grow into the country's new growth engine in a shifting environment.


Related Content

US Approval Delay For Green Cross But Long Term Strategy Intact
Trump Victory To Breathe Life Into Korean Biopharmas?


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts